Qiagen Draws Early Takeover Interest From EQT, Advent

Qiagen NV, a European molecular testing company, is attracting early takeover interest from private equity firms, including EQT AB and Advent. This development has been reported by individuals familiar with the matter. Following the news of this potential acquisition interest from the buyout firms, the stock price of Qiagen has experienced a jump. The company remains a focal point for these investment firms as they explore a possible takeover of the molecular testing business.